Media thread, page-556

Comments around here have seemingly dried up since my last little skirmish with @bedger and his scholarly sermon on my inability to read pre-Market figures, but it appears our Ice berg seller is still hitting the bid.

If it is whom I suspect, he must surely not have too many left to go. We have both the Singapore Regulatory Application for Remplir due around mid Oct, and the ph2 Sensory & Motor function as well as the ph3 Quality Regen studies due around the end of Sept. (hopefully around the 9th) to be released.

I have been buying parcels here and there with a few bids scattered throughout the stack to catch more selling pressure. The cheaper this goes the better the buying. Fundamentals of the business haven't changed, only the share price/chart has, which at present, are obviously not correlated

From The Guardian Western Australia
https://www.theguardian.com/western...tern-australia-a-powerful-innovator-in-health



Open Day to celebrate WA health and medical innovation

The next Future Health Research and Innovation (FHRI) Fund Open Day will be held on 18 July and will showcase the State’s brightest health and medical innovators.

The event will be hosted by the WA Department of Health’s Office of Medical Research and Innovation (OMRI) in collaboration with the WA Life Sciences Innovation Hub (WALSIH), under the theme: ‘a connected innovation ecosystem’.

Attendees will have the opportunity to hear about developments related to local health and medical innovation, learn about new FHRI Fund programs, and hear successful FHRI Fund recipients showcase their innovation projects through a captivating ‘Early-stage Biomedical and Health Showcase’.

Speakers will include prominent identities in the WA health and medical innovation space, including new FHRI Fund Advisory Council member, Professor Fiona Wood AO.